EVOGENE LTD (EVGN) Stock Price & Overview
NASDAQ:EVGN • IL0011050551
Current stock price
The current stock price of EVGN is 0.766 USD. Today EVGN is down by -1.79%. In the past month the price decreased by -2.27%. In the past year, price decreased by -35.08%.
EVGN Key Statistics
- Market Cap
- 6.68M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.17
- Dividend Yield
- N/A
EVGN Stock Performance
EVGN Stock Chart
EVGN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to EVGN. When comparing the yearly performance of all stocks, EVGN is a bad performer in the overall market: 90.21% of all stocks are doing better.
EVGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to EVGN. EVGN has a bad profitability rating. Also its financial health evaluation is rather negative.
EVGN Earnings
On March 5, 2026 EVGN reported an EPS of -0.61 and a revenue of 314.00K. The company missed EPS expectations (-130.02% surprise) and beat revenue expectations (11.94% surprise).
EVGN Forecast & Estimates
7 analysts have analysed EVGN and the average price target is 1.79 USD. This implies a price increase of 133.03% is expected in the next year compared to the current price of 0.766.
For the next year, analysts expect an EPS growth of -30.77% and a revenue growth -61.68% for EVGN
EVGN Financial Highlights
Over the last trailing twelve months EVGN reported a non-GAAP Earnings per Share(EPS) of -1.17. The EPS increased by 62.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -42.33% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EVGN Ownership
EVGN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 12.59 | 373.774B | ||
| AMGN | AMGEN INC | 13.88 | 186.868B | ||
| GILD | GILEAD SCIENCES INC | 14.89 | 162.401B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 21.77 | 108.708B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 74.75B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 27.54 | 41.295B | ||
| INSM | INSMED INC | N/A | 29.427B | ||
| NTRA | NATERA INC | N/A | 29.219B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 28.56B | ||
| BIIB | BIOGEN INC | 11.44 | 27.779B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.52 | 25.042B | ||
| INCY | INCYTE CORP | 10.61 | 18.96B | ||
| MRNA | MODERNA INC | N/A | 18.219B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About EVGN
Company Profile
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
IPO: 2007-06-11
EVOGENE LTD
13 Gad Feinstein Street, Park Rehovot
Rehovot 7414002 IL
CEO: Ofer Haviv
Employees: 117
Phone: 97289311900
EVOGENE LTD / EVGN FAQ
Can you describe the business of EVOGENE LTD?
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
What is the stock price of EVOGENE LTD today?
The current stock price of EVGN is 0.766 USD. The price decreased by -1.79% in the last trading session.
What is the dividend status of EVOGENE LTD?
EVGN does not pay a dividend.
What is the ChartMill technical and fundamental rating of EVGN stock?
EVGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Is EVOGENE LTD (EVGN) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on EVGN.
How many employees does EVOGENE LTD have?
EVOGENE LTD (EVGN) currently has 117 employees.